Legence Corp. LGN
52.52
0.07
0.13%
as of 25 Sep
- Market cap
- $5.7B
- P/E
- 0.0×
Follow LGN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+5 more quarters Free account |
P/S ratio |
1.73 | 1.23 | 1.00 | 0.76 | |
P/FCF ratio |
20.02 | 12.74 | 11.65 | 13.11 | |
P/Operating CF |
87.12 | 31.57 | 26.97 | 18.10 | |
P/B ratio |
6.63 | 3.99 | 3.24 | 2.18 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.93 | 1.48 | 1.24 | 1.03 | |
EV/EBITDA |
32.70 | 20.57 | 15.44 | 12.24 | |
EV/Operating CF |
18.58 | 13.16 | 12.28 | 14.60 | |
EV/FCF |
22.32 | 15.37 | 14.38 | 17.86 | |
Quick Ratio |
0.99 | 0.95 | 1.15 | 1.16 | |
Current Ratio |
1.35 | 1.30 | 1.57 | 1.57 | |
Net Debt/EBITDA |
12.46 | 12.03 | 19.56 | 9.95 | |
Debt/Assets |
27.66% | 29.49% | 30.94% | 31.88% | |
Debt/Equity |
1.06 | 1.08 | 1.05 | 1.00 | |
Asset Turnover |
2.00 | 1.77 | 1.90 | 1.83 | |
Operating CF/Net income |
(2.67) | 7.46 | (2.90) | (172.89) | |
Capex/Depreciation |
(0.36) | (0.41) | (0.24) | (0.37) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.69% | 11.19% | 15.56% | 12.13% | |
Intangible Assets out of Total Assets |
0.43 | 0.48 | 0.49 | 0.52 | |
Share Based Compensation of Revenue |
5.97% | 3.53% | 6.19% | 2.63% | |
Graham Net Nets |
(0.17) | (0.28) | (0.31) | (0.41) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.79%) | (0.79%) | (0.79%) | (0.79%) | |
Free Cash Flow Yield |
4.99% | 7.85% | 8.58% | 7.63% | |
Revenue per Share |
16.60 | 15.46 | 12.42 | 12.10 | |
Operating CF per Share |
0.98 | 1.79 | 1.60 | 1.70 | |
Capex per Share |
(0.32) | (0.26) | (0.22) | (0.18) | |
Free Cash Flow per Share |
0.66 | 1.53 | 1.38 | 1.52 | |
Cash per Share |
3.84 | 3.64 | 3.88 | 3.01 | |
Shareholders Equity per Share |
12.86 | 14.16 | 13.28 | 14.14 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.86 | 14.16 | 13.28 | 14.14 | |
Free Cash Flow |
50.42 | 102.42 | 81.71 | 89.07 | |
Working Capital |
423.51 | 337.19 | 402.19 | 377.81 | |
Capital Expenditures |
(23.96) | (17.69) | (13.04) | (10.51) | |
Net Current Asset Value |
(1,113.97) | (1,061.47) | (780.25) | (734.99) | |
EV/EBIT |
245.27 | 67.87 | 51.23 | 21.92 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 | |
Net Profit Margin |
(2.21%) | 1.55% | (4.44%) | (0.08%) | |
Price to Operating Income |
220.06 | 56.26 | 41.50 | 16.09 | |
| Other line items | |||||
Average Receivables |
683.77 | — | — | — | |
Average Payables |
277.75 | — | — | — | |
Average Assets |
1,869.84 | 1,741.55 | 1,339.70 | 1,300.13 | |
Average Common Equity |
590.57 | — | — | — |
Columns are period end dates